Self-guided treatment for patients with panic disorder and agoraphobia Mental and Behavioural Disorders
Conditions
Interventions
First, all patients will have two psychotherapeutic sessions during which their symptoms will be assessed. At the end of the second session, random allocation to the research conditions will take plac
Sponsors
University of Siegen
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: One of the following diagnostic criteria: - Agoraphobia, unspecified (ICD-10 F40.00) - Agoraphobia with panic disorder (ICD-10 F40.01) - Agoraphobia without panic disorder (ICD-10 F40.02) - Panic disorder (ICD-10 F41.0) Note: All listed diagnoses can be in comorbidity with or without depression
Exclusion criteria
Exclusion criteria: 1. Stroke or myocardial infarction in patient history 2. Angina pectoris 3. Cardiac dysrhythmia 4. Asthma, chronic obstructive pulmonary disease 5. Pregnancy (or assumed pregnancy) 6. Severely impaired vision 7. Epilepsy or other cramp attacks in patient history 8. Psychological disorder with organic origin (f.e. dementia) 9. Dizziness or vestibular impairment 10. Psychological disorder due to use of psychoactive substances 11. Schizophrenia, schizotypal or delusional disorder 12. Severe depression 13. Acute suicidality or missing agreement in presence of suicidality
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Panic disorder and agoraphobia symptoms are measured using the German version of the Panic and Agoraphobia Scale (PAS) at baseline, interim (6 weeks), post-treatment (10 weeks), and follow-up (16 weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| Remission measured using the Mini-DIPS at baseline and follow-up (16 weeks) | — |
Countries
Germany
Outcome results
None listed